When medicines are first marketed, knowledge of rare serious harmful effects is limited, because generally too few people are exposed, trials are too brief, and vulnerable groups such as elderly people have been excluded. 1 Harm from medicine use is an important public health concern, leading to many potentially preventable hospital admissions and deaths. 2 -4 Early signals of serious harm, supported by evidence and acted on promptly, could lead to improved patient and public health.